Search
Patexia Research
Case number 1:17-cv-01164

Teva Pharmaceuticals International GmbH et al v. Apotex Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Jul 6, 2020 N/A Terminated Case (0)
Docket Text: CASE CLOSED per Final Judgment Order in Lead Case. CA. NO. 17-1154-CFC. (fms)
Feb 8, 2019 23 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of First Supplemental Objections and Answers to Plaintiffs' First Set of Interrogatories filed by Apotex Corp., Apotex Inc..(Cole, Jeremy)
Sep 25, 2018 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-CFC, 1:17-cv-01164-CFC, 1:17-cv-01201-CFC, 1:17-cv-01790-CFC, 1:18-cv-00117-CFC (rjb)
Jul 25, 2018 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-LPS, 1:17-cv-01164-LPS, 1:17-cv-01201-LPS, 1:17-cv-01790-LPS, 1:18-cv-00117-LPS (rjb)
Dec 13, 2017 N/A Remark (0)
Docket Text: Remark - These cases have been consolidated for ALL PURPOSED. All future filings shall be made ONLY in Lead C.A. No. 17-1154-GMS. Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(mdb)
Dec 13, 2017 N/A Scheduling Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 12/13/2017. Discussion about the competing schedule proposals between the parties. After counsel conferred outside of court's presence, the court assigns the following dates: A Markman Hearing (full day) is set for 9/4/2018 at 9:30 AM in Courtroom 4A, the Final Proposed Pretrial Order is due by the close of business on 7/29/2019, the Final Pretrial Conference is set for 8/19/2019 at 10:00 AM in Courtroom 4A, and a 10-day Bench Trial is set for 9/3/2019 at 9:00 AM in Courtroom 4A. These cases are consolidated for all purposes; all future filings are to be made ONLY in Lead C.A. No. 17-1154-GMS. These cases will not be referred to the Magistrate Judge for exploring ADR. The plaintiffs shall file an amended scheduling order within seven (7) days of today. (Court Reporter Kevin Maurer.) Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(mdb)
Dec 7, 2017 22 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Identification of Asserted Patents and Accused Products filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen)
Dec 5, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Sherry L. Rollo and Steven E. Feldman for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg)
Dec 1, 2017 N/A Oral Order (0)
Docket Text: ORAL ORDER re (20 in 1:17-cv-01201-GMS, 18 in 1:17-cv-01154-GMS, 15 in 1:17-cv-01164-GMS) Joint Status Report - A Scheduling Conference is set for Wednesday, December 13, 2017 at 10:00 AM (EST)in Courtroom 4A. Ordered by Judge Gregory M. Sleet on 12/1/2017. Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(mdb)
Dec 1, 2017 N/A SO ORDERED (0)
Docket Text: SO ORDERED - re [20] MOTION for Pro Hac Vice Appearance of Attorney Steven E. Feldman and Sherry L. Rollo filed by Apotex Inc., Apotex Corp.. Ordered by Judge Gregory M. Sleet on 12/1/2017. (mdb)
Nov 28, 2017 21 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Apotex Corp., Apotex Inc. (Haney, Megan)
Nov 28, 2017 20 Rollo Pro Hac Certification (1)
Nov 28, 2017 20 Feldman Pro Hac Certification (1)
Nov 28, 2017 20 Motion for Leave to Appear Pro Hac Vice (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven E. Feldman and Sherry L. Rollo - filed by Apotex Corp., Apotex Inc.. (Attachments: # (1) Feldman Pro Hac Certification, # (2) Rollo Pro Hac Certification)(Phillips, John)
Nov 27, 2017 19 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp.. (Phillips, John)
Nov 27, 2017 18 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Apotex Inc.. (Phillips, John)
Nov 27, 2017 17 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, with Jury Demand, Affirmative Defenses and, COUNTERCLAIM against Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH by Apotex Corp., Apotex Inc..(Phillips, John) Modified on 11/27/2017 (mdb).
Nov 7, 2017 16 Proposed Order (13)
Docket Text: PROPOSED ORDER [Scheduling Order] by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan)
Nov 7, 2017 15 Status Report (12)
Docket Text: Joint STATUS REPORT by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan)
Oct 20, 2017 N/A SO ORDERED (0)
Docket Text: SO ORDERED - re [14] STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to November 27, 2017 filed by Apotex Inc., Apotex Corp., Set/Reset Answer Deadlines: Apotex Corp. answer due 11/27/2017; Apotex Inc. answer due 11/27/2017. Ordered by Judge Gregory M. Sleet on 10/20/2017. (mdb)
Oct 18, 2017 14 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to November 27, 2017 - filed by Apotex Corp., Apotex Inc.. (Phillips, John)
Oct 18, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Kenneth G. Schuler for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01164-GMS, 1:17-cv-01154-GMS, 17-cv-1201-GMS(crb)
Oct 13, 2017 N/A SO ORDERED (0)
Docket Text: SO ORDERED - re (13 in 1:17-cv-01164-GMS, 15 in 1:17-cv-01154-GMS) MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler filed by Eagle Pharmaceuticals, Inc. Ordered by Judge Gregory M. Sleet on 10/13/2017. Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01164-GMS(mdb)
Oct 12, 2017 13 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan)
Oct 12, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Daniel G. Brown, Michelle L. Ernst, and Marc N. Zubick for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
Oct 12, 2017 N/A SO ORDERED (0)
Docket Text: SO ORDERED - re (15 in 1:17-cv-01201-GMS, 14 in 1:17-cv-01154-GMS, 12 in 1:17-cv-01164-GMS) MOTION for Pro Hac Vice Appearance of Attorney Marc N. Zubick, Daniel G. Brown, and Michelle L. Ernst filed by Eagle Pharmaceuticals, Inc.. Ordered by Judge Gregory M. Sleet on 10/12/2017. Associated Cases: 1:17-cv-01164-GMS, 1:17-cv-01154-GMS, 1:17-cv-01201-GMS(mdb)
Oct 11, 2017 12 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Marc N. Zubick, Daniel G. Brown, and Michelle L. Ernst - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan)
Sep 12, 2017 N/A SO ORDERED (0)
Docket Text: SO ORDERED - re [11] STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to October 23, 2017 filed by Apotex Inc., Apotex Corp., Set/Reset Answer Deadlines: Apotex Corp. answer due 10/23/2017; Apotex Inc. answer due 10/23/2017. Ordered by Judge Gregory M. Sleet on 9/12/2017. (mdb)
Sep 11, 2017 11 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to October 23, 2017 - filed by Apotex Corp., Apotex Inc.. (Phillips, John)
Sep 6, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Shaun P. Mahaffy for Cephalon, Inc., and for Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
Sep 6, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney David I. Berl for Cephalon, Inc., and for Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(lmm)
Sep 6, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Adam D. Harber for Cephalon, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(lmm)
Sep 6, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Adam D. Harber for Teva Pharmaceuticals International GmbH, added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(lmm)
Sep 6, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Martha C. Kidd for Cephalon, Inc., and for Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
Sep 1, 2017 N/A SO ORDERED (0)
Docket Text: SO ORDERED - re (10 in 1:17-cv-01164-GMS, 9 in 1:17-cv-01201-GMS) MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber, Martha C. Kidd and Shaun P. Mahaffy filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. Ordered by Judge Gregory M. Sleet on 9/1/2017. Associated Cases: 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(mdb)
Aug 30, 2017 10 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber, Martha C. Kidd and Shaun P. Mahaffy - filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan)
Aug 24, 2017 9 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Teva Pharmaceuticals International GmbH, Cephalon, Inc., Eagle Pharmaceuticals, Inc.. Apotex Inc. served on 8/22/2017, answer due 9/12/2017. (Hoeschen, Nathan)
Aug 23, 2017 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-UNA, 1:17-cv-01164-UNA (rjb)
Aug 21, 2017 8 Return of Service Executed (2)
Docket Text: Return of Service Executed by Teva Pharmaceuticals International GmbH, Cephalon, Inc., Eagle Pharmaceuticals, Inc.. Apotex Corp. served on 8/21/2017, answer due 9/11/2017. (Hoeschen, Nathan)
Aug 21, 2017 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 8/21/2017; Apotex Inc. on 8/21/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs)
Aug 18, 2017 1 A (29)
Aug 18, 2017 7 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (jcs)
Aug 18, 2017 6 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc. (jcs)
Aug 18, 2017 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Cephalon, Inc. filed by Cephalon, Inc.(jcs)
Aug 18, 2017 4 Patent/Trademark Report to Commissioner (3)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,609,707 B2; US 8,791,270 B2; US 9,000,021 B2; US 9,034,908 B2; US 9,144,568 B1. (jcs)
Aug 18, 2017 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 7, 2017. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 1/7/2020. (jcs)
Aug 18, 2017 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs)
Aug 18, 2017 1 Civil Cover Sheet (1)
Aug 18, 2017 1 M (8)
Aug 18, 2017 1 L (7)
Aug 18, 2017 1 K (13)
Aug 18, 2017 1 J (13)
Aug 18, 2017 1 I (13)
Aug 18, 2017 1 H (18)
Aug 18, 2017 1 G (12)
Aug 18, 2017 1 F (13)
Aug 18, 2017 1 E (10)
Aug 18, 2017 1 D (10)
Aug 18, 2017 1 C (9)
Aug 18, 2017 1 B (9)
Aug 18, 2017 1 Complaint* (1)
Menu